Clinical cardiopulmonary bypass without systemic anticoagulation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8239824.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Heparin-coated perfusion systems have been used to perform cardiopulmonary bypass with decreased systemic heparin dosages. We report the case of a 60-year-old man with end-stage liver disease and severe aortic stenosis who underwent an aortic valve replacement without systemic anticoagulation, employing a heparin-coated perfusion system. In patients with a contraindication to systemic anticoagulation, cardiopulmonary bypass with a heparin-coated system without systemic anticoagulation may be a viable alternative.
Medical subject headings
- Aortic Valve Stenosis
- Cardiopulmonary Bypass
- Heart Valve Prosthesis
- Liver Failure